Business Context and Reporting Period
Company: Chicago Mercantile Exchange Holdings Inc. (CME Group Inc.)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2005
Business Overview: CME operates a global derivatives marketplace, offering futures and options on interest rates, equities, foreign exchange, and commodities. The company provides clearing, settlement, and market data services. Key platforms include CME Globex (electronic trading) and open outcry facilities.
Key Financial Metrics
| Metric | Nine Months Ended Sep 30, 2005 | Nine Months Ended Sep 30, 2004 | Three Months Ended Sep 30, 2005 | Three Months Ended Sep 30, 2004 |
|---|---|---|---|---|
| Total Revenues | $725.7 million | $556.8 million | $249.6 million | $196.7 million |
| Net Revenues (after securities lending expense) | $687.6 million | $545.8 million | $234.3 million | $192.4 million |
| Net Income | $230.6 million | $162.8 million | $77.5 million | $59.4 million |
| Diluted EPS | $6.63 | $4.74 | $2.22 | $1.72 |
| Operating Cash Flow | $273.6 million | $227.4 million | N/A | N/A |
| Cash and Equivalents (Sep 30, 2005) | $585.7 million | $357.6 million (Dec 31, 2004) | N/A | N/A |
| Trading Volume (Avg Daily Contracts) | 4.2 million (9mo) | 3.1 million (9mo) | 4.2 million (3mo) | 3.2 million (3mo) |
Material Changes vs. Prior Period
- Revenue Growth: Net revenues increased 26% year-over-year for the nine-month period, driven primarily by a 34% increase in average daily trading volume. Clearing and transaction fees rose $105.9 million.
- Profitability: Net income increased 42% to $230.6 million for the nine months ended September 30, 2005. The effective tax rate decreased to 39.7% from 40.5% due to increased tax-exempt income and favorable audit resolutions.
- Volume Drivers: Electronic trading volume on CME Globex surged 70% year-over-year, now representing 69% of total volume. Growth was led by interest rate, equity E-mini, and foreign exchange products.
- Expense Increases: Total operating expenses rose $32.8 million, primarily due to higher compensation ($11.9 million increase), depreciation and amortization ($8.6 million increase), and technology-related professional fees.
- Securities Lending: Net revenue from securities lending increased significantly due to higher market interest rates and larger average balances, though this is largely offset by corresponding interest expense.
Guidance, Outlook, and Risks
- Outlook: Management expects annual operating expenses for 2005 to increase by the upper end of the previously disclosed range of 11% to 13%, driven by technology spending and bandwidth expansion.
- Seasonality: The company typically experiences lower volume levels in the fourth quarter due to the seasonality of the futures business.
- Strategic Initiatives: CME launched "CME Economic Derivatives" in September 2005 and plans to make them available on the Globex platform in Q1 2006. The company is also expanding electronic trading capabilities in Europe and Asia.
- Risks and Contingencies:
- Legal Proceedings: Ongoing antitrust litigation with Eurex U.S. (venue transferred to Northern District of Illinois); a former employee's appeal regarding retaliatory discharge is pending; a lawsuit with McGraw-Hill regarding S&P index licenses was settled/closed in September 2005.
- Market Risk: Exposure to interest rate fluctuations affecting investment income and fair value of marketable securities. Derivatives trading risk via subsidiary GFX is hedged and considered not significant.
- Competition: Risks from foreign and domestic competitors, new entrants, and the need to maintain technological leadership.
- Accounting Changes: CME will adopt SFAS No. 123R (Share-Based Payment) effective January 1, 2006, which will change the classification of excess tax benefits from operating to financing cash flows.
Investor Verification Checklist
- Volume Sustainability: Verify if the 34% year-over-year volume growth is sustainable given the noted seasonality in Q4 and potential market volatility shifts.
- Fee Structure Impact: Assess the long-term impact of the declining average rate per contract ($0.659 in 2005 vs. $0.702 in 2004) caused by competitive incentives and product mix shifts.
- Legal Exposure: Monitor the status of the antitrust suit filed by Eurex U.S., which seeks treble damages, and the outcome of the former employee's appeal.
- Capital Allocation: Review the $62.3 million in capital expenditures for the nine-month period, 93% of which was technology-related, to ensure alignment with revenue growth.
- Dividend Policy: Note the increase in quarterly dividends to $0.46 per share (from $0.26 in 2004) and the total payout of $47.4 million for the nine-month period.